Molecular mechanisms of metastasis

Cancer Letters

Volumn 270, Issue 2, 2008, Pages 181-190

  Weber, Georg F ^a  

^a UNIVERSITY OF CINCINNATI ACADEMIC HEALTH CENTER   (United States)

Author keywords

Anchorage independence; Invasion; Metastasis; Oncogene; Stress response

Indexed keywords

ALKYLATING AGENT; ANGIOGENESIS INHIBITOR; ANTIMETABOLITE; ANTIMITOTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; B RAF KINASE; CD44V ANTIGEN; CHLORMETHINE; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; HEAT SHOCK PROTEIN; HOMING RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ISONIAZID; LIGAND; NEUTRALIZING ANTIBODY; NUCLEOSIDE ANALOG; OSTEOPONTIN; PHOSPHOTRANSFERASE INHIBITOR; PREDNISONE; PROCARBAZINE; PROTEIN RET; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TELOMERASE INHIBITOR; TRANSCRIPTION FACTOR; UNINDEXED DRUG; VINCA ALKALOID; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANCHORAGE INDEPENDENT GROWTH; CANCER CELL; CANCER INVASION; CELL CYCLE PROGRESSION; CELL HOMING; DRUG TARGETING; EPIGENETICS; GENE EXPRESSION REGULATION; HUMAN; IMMUNOCOMPETENT CELL; METASTASIS; NEOPLASM; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA SPLICING; SHORT SURVEY; SIGNAL TRANSDUCTION; TUBERCULOSIS; TUMOR GENE;

EID: 52149088558     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.04.030     Document Type: Review

References (49)

1. Weber G.F. Molecular Mechanisms of Cancer (2007), Springer, Dordrecht
2. de Lange T. Activation of telomerase in a human tumor. Proc. Natl. Acad. Sci. USA 91 (1994) 2882-2885
3. Fidler I.J. Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35 (1975) 218-224
4. Ramshaw I.A., Carlsen S., Wang H.C., and Badenoch-Jones P. The use of cell fusion to analyse factors involved in tumour cell metastasis. Int. J. Cancer 32 (1983) 471-478
5. Sidebottom E., and Clark S.R. Cell fusion segregates progressive growth from metastasis. Br. J. Cancer 47 (1983) 399-405
6. Layton M.G., and Franks L.M. Selective suppression of metastasis but not tumorigenicity of a mouse lung carcinoma by cell hybridization. Int. J. Cancer 37 (1986) 723-730
7. Turpeenniemi-Hujanen T., Thorgeirsson U.P., Hart I.R., Grant S.S., and Liotta L.A. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential. J. Natl. Cancer Inst. 75 (1985) 99-103
8. Matrisian L.M., Bowden G.T., Krieg P., Furstenberger G., Briand J.P., Leroy P., and Breathnach R. The mRNA coding for the secreted protease transin is expressed more abundantly in malignant than in benign tumors. Proc. Natl. Acad. Sci. USA 83 (1986) 9413-9417
9. Günthert U., Hofmann M., Rudy W., Reber S., Zöller M., Hausmann I., Matzku S., Wenzel A., Ponta H., and Herrlich P. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65 (1991) 13-24
10. Steeg P.S., Bevilacqua G., and Kopper L. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst. 80 (1988) 200-204
11. Alvarez O.A., Carmichael D.F., and DeClerck Y.A. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J. Natl. Cancer Inst. 82 (1990) 589-595
12. Weber G.F., and Ashkar S. Stress response genes - the genes that make cancer metastasize. J. Mol. Med. 78 (2000) 404-408
13. Weber G.F., and Ashkar S. Molecular mechanisms of tumor dissemination in primary and metastatic brain cancers. Brain Res. Bull. 53 (2000) 421-424
14. Ashkar S., Weber G.F., Panoutsakopoulou V., Sanchirico M.E., Janssen M., Zawaideh S., Rittling S., Denhardt D.T., Glimcher M.J., and Cantor H. Eta-1 (Osteopontin): an early component of type 1 (cell-mediated) immunity. Science 287 (2000) 860-864
15. Stéhelin D., Varmus H.E., Bishop J.M., and Vogt P.K. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 260 (1976) 170-173
16. Culty M., Miyake K., Kincade P.W., Sikorski E., Butcher E.C., and Underhill C. The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J. Cell Biol. 111 (1990) 2765-2774
17. Arch R., Wirth K., Hofmann M., Ponta H., Matzku S., Herrlich P., and Zöller M. Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257 (1992) 682-685
18. Tanabe K.K., Stamenkovic I., Cutler M., and Takahashi K. Restoration of CD44H expression in colon carcinomas reduces tumorigenicity. Ann. Surg. 222 (1995) 493-501
19. Weber G.F., Bronson R., Ilagan J., Cantor H., Schmitz R., and Mak T.W. Absence of CD44 prevents sarcoma metastasis. Cancer Res. 62 (2002) 2281-2286
20. Weber G.F., Ashkar S., Glimcher M.J., and Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 271 (1996) 509-512 (erratum: Science 282 (1998) 243)
21. Weber G.F., Ashkar S., and Cantor H. Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc. Assoc. Am. Phys. 109 (1997) 1-9
22. Weber G.F., Zawaideh S., Kumar V.A., Glimcher M.J., Cantor H., and Ashkar S. Phosphorylation-dependent interaction of osteopontin with its receptors regulates macrophage migration and activation. J. Leukoc. Biol. 72 (2002) 751-761
23. Weber G., and Cantor H. The immunology of Eta-1/Osteopontin. Cytokines Growth Factor Rev. 7 (1996) 241-248
24. G.F. Weber, The next interleukin? Science's STKE 147:PE37. Available from: .
25. Craig-Mylius C., Weber G.F., Coburn J.L., and Glickstein L.G. Borrelia burgdorferi, an extracellular pathogen, circumvents osteopontin in inducing an inflammatory cytokine response. J. Leukoc. Biol. 77 (2005) 710-718
26. Weber G.F., and Cantor H. Differential roles of osteopontin/Eta-1 in early and late lpr disease. Clin. Exp. Immunol. 126 (2001) 578-583
27. lpr/lpr disease. Autoimmunity 37 (2004) 1-8
28. Mirza M., Shaughnessy E., Hurley J.K., Vanpatten K.A., Pestano G.A., He B., and Weber G.F. Osteopontin-c is a highly selective marker for breast cancer. Int. J. Cancer 122 (2008) 889-897
29. He B., Mirza M., and Weber G.F. An osteopontin splice variant induces anchorage independence in human breast cancer. Oncogene 25 (2006) 2192-2202
30. Adler B., Ashkar S., Cantor H., and Weber G.F. Costimulation through adhesion molecules determines the response to ligation of the T-cell antigen receptor. Cell Immunol. 210 (2001) 30-40
31. Glinsky G.V., and Glinsky V.V. Apoptosis and metastasis: a superior resistance of metastatic cancer cells to programmed cell death. Cancer Lett. 101 (1996) 43-51
32. Takaoka A., Adachi M., Okuda H., Sato S., Yawata A., Hinoda Y., Takayama S., Reed J.C., and Imai K. Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene 14 (1997) 2971-2977
33. Wong C.W., Lee A., Shientag L., Yu J., Dong Y., Kao G., Al-Mehdi A.B., Bernhard E.J., and Muschel R.J. Apoptosis: an early event in metastatic inefficiency. Cancer Res. 61 (2001) 333-338
34. Weber G.F., Adler B., and Ashkar S. Osteopontin in oxidative stress responses. In: Ruffolo Jr. R.R., Feuerstein G.Z., Hunter A.J., Poste G., and Metcalf B.W. (Eds). Inflammatory Cells and Mediators in CNS Diseases (1999), Harwood Academic Publishers, Amsterdam 97-112
35. Denhardt D.T., Lopez C.A., Rollo E.E., Hwang S.M., An X.R., and Walther S.E. Osteopontin-induced modifications of cellular functions. Ann. NY Acad. Sci. 760 (1995) 127-142
36. Weber G.F. Final common pathways in neurodegenerative diseases: regulatory role of the glutathione cycle. Neurosci. Biobehav. Rev. 23 (1999) 1079-1086
37. Yang X.F., Weber G.F., and Cantor H. A novel BCL-X isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity 7 (1997) 629-639
38. Zhang G., He B., and Weber G.F. A molecular connection between breast cancer cell proliferation and metastasis mediated by Akt kinase. Mol. Cell. Biol. 23 (2003) 6507-6519
39. Whalen K.A., Weber G.F., Benjamin T.L., and Schaffhausen B.S. Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for migration of transformed cells. J. Virol. 82 (2008) 4946-4954
40. V600E oncoproteins in thyroid cells is associated with unique patterns of gene expression that predict distinct functional properties and a preferential role of BRAF in extracellular matrix remodeling. Cancer Res. 66 (2006) 6521-6529
41. Weber G.F., Abromson-Leeman S., and Cantor H. A signalling pathway coupled to T cell receptor ligation by MMTV superantigen leading to transient activation and programmed cell death. Immunity 2 (1995) 363-372
42. He B., and Weber G.F. Phosphorylation of NF-κB proteins by cyclic GMP-dependent kinase: A non-canonical pathway to NF-κB activation. Eur. J. Biochem. 270 (2003) 2174-2185
43. He B., and Weber G.F. Synergistic activation of the CMV promoter by NF-κB P50 and Cyclic GMP-Dependent Kinase. Biochem. Biophys. Res. Commun. 321 (2004) 13-20
44. Zhong H., SuYang H., Erdjument-Bromage H., Tempst P., and Ghosh S. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89 (1997) 413-424
45. Zhong H., Voll R.E., and Ghosh S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol. Cell 1 (1998) 661-671
46. Jiang J., Wei Y., Shen J., Liu D., Chen X., Zhou J., Zong H., Yun X., Kong X., Zhang S., Yang Y., and Gu J. Functional interaction of E1AF and Sp1 in glioma invasion. Mol. Cell. Biol. 27 (2007) 8770-8782
47. Ozanne B.W., Spence H.J., McGarry L.C., and Hennigan R.F. Transcription factors control invasion: AP-1 the first among equals. Oncogene 26 (2007) 1-10
48. Weber G.F. The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim. Biophys. Acta 1552 (2001) 61-85. http://www.elsevier.com/gej-ng/10/38/20/70/31/28/main.pdf ROCO:
49. In: Weber G.F. (Ed). Cancer Therapy: Molecular Targets in Tumor-Host Interactions (2005), Horizon Press, Wymondham